Quick Answer
Zomedica Corp. reported Diluted EPS of $0.08 per share (loss) for fiscal year 2025.
Zomedica Corp. Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | -$0.08 | -60.0% |
| 2024 | -$0.05 | -25.0% |
| 2023 | -$0.04 | -135.3% |
| 2022 | -$0.02 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$0.01 | +0.0% | +0.0% |
| June 30, 2025 | -$0.01 | +50.0% | +85.7% |
| March 31, 2025 | -$0.07 | -600.0% | -600.0% |
| September 30, 2024 | -$0.01 | — | +50.0% |
| June 30, 2024 | -$0.02 | -300.0% | -100.0% |
| March 31, 2024 | -$0.01 | -42.9% | — |
| September 30, 2023 | $0.00 | +100.0% | +100.0% |
| June 30, 2023 | -$0.01 | +0.0% | +28.6% |
- Zomedica Corp. showed a decrease of -60.0% in Diluted EPS compared to the prior fiscal year.
- Over the 2022–2025 period, Zomedica Corp.’s diluted eps has declined by 370.6% (from $0.02 per share (loss) to $0.08 per share (loss)).
- The most recent figure is from Zomedica Corp.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 16, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: